Ennature Bio Pharma Reports Rs 4.89 Crore Profit in Q2 Post-Demerger
Ennature Bio Pharma reported a profit after tax of Rs 4.89 crore in the second quarter of FY27, reversing a loss of Rs 1.28 crore in the same period last year. The company's revenue increased to Rs 78.46 crore from Rs 54.14 crore, and EBITDA rose to Rs 10.34 crore from Rs 6.04 crore. These are the first quarterly results following its demerger from India Glycols Ltd, according to company statements.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (55/100). Lens Score 34/100.
Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 14 Nov, 12:16 pm. Other outlets followed.
- 1